VivoSeq
Other

Heroin Dependence

14

Pipeline Programs↗

0

Active Trials↗

9

Companies Involved↗

Heroin Dependence is an emerging landscape with 14 programs across 9 companies. The most active players are Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), AbbVie, Hikma Pharmaceuticals LLC. 9 therapies are approved with 2 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

41/100

Pipeline Velocity

0/100

Mech. Concentration

20/100

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

C

Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

1 program

Phase 1AbbVie logo

AbbVie

1 program

Phase 3H

Hikma Pharmaceuticals LLC

1 program

ApprovedS

Scienture

1 program

ApprovedTeva logo

Teva

1 program

ApprovedB

BioCorRx Pharmaceuticals Inc

1 program

Approved

Pipeline

Programs by Phase

Analysis

Trial Status

5

clinical trials

Completed5 · 100%

Clinical Trials

Trial Activity

Aprepitant Effects in Intravenous Heroin Dependence
Completed·NNYU Langone Health·Phase 1·NCT01527994·64 enrolled
Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens
Completed·National Institute on Drug Abuse (NIDA)·Phase 2·NCT00218127·142 enrolled
Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence
Completed·NNew York State Psychiatric Institute·Phase 2·NCT00332228·125 enrolled
Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14
Completed·National Institute on Drug Abuse (NIDA)·Phase 4·NCT00015340·582 enrolled
Memantine as a Supplement to Naltrexone in Treating Heroin Dependence
Completed·NNew York State Psychiatric Institute·Phase 2/3·NCT00476242·82 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)